Sensus Healthcare (SRTS) Current Deferred Revenue (2015 - 2026)
Sensus Healthcare's (SRTS) quarterly Current Deferred Revenue came in at $639000.0 in Q1 2026, up 16.18% year-on-year from $550000.0 in Q1 2025, and down 24.11% quarter-over-quarter from $842000.0 in Q4 2025.
Sensus Healthcare (SRTS) Current Deferred Revenue (2015 - 2026) Analysis & Trends
Sensus Healthcare's Current Deferred Revenue history runs 12 years deep, the most recent figure standing at $639000.0 for Q1 2026.
- On a quarterly basis, Current Deferred Revenue rose 16.18% year-over-year to $639000.0 in Q1 2026; TTM through Mar 2026 was $639000.0, a 16.18% increase from a year earlier, with the FY2025 full-year figure at $842000.0, up 55.64% from the prior year.
- Current Deferred Revenue eased to $639000.0 in Q1 2026 per SRTS's latest filing, from $842000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $1.2 million in Q2 2022 and bottomed at $529000.0 in Q2 2025.
- The 5-year median for Current Deferred Revenue is $692000.0 (2023), against an average of $771764.7.
- Across the five-year window, Current Deferred Revenue plunged 51.67% in 2022 and soared 55.64% in 2025, its largest moves.
- Year by year, Current Deferred Revenue stood at $693000.0 in 2022, then slipped by 5.19% to $657000.0 in 2023, then decreased by 17.66% to $541000.0 in 2024, then jumped by 55.64% to $842000.0 in 2025, then decreased by 24.11% to $639000.0 in 2026.
- Per Business Quant, the three latest SRTS Current Deferred Revenue figures stand at $639000.0 (Q1 2026), $842000.0 (Q4 2025), and $648000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 639,000.00 |
| Dec 31, 2025 | 842,000.00 |
| Sep 30, 2025 | 648,000.00 |
| Jun 30, 2025 | 529,000.00 |
| Mar 31, 2025 | 550,000.00 |
| Dec 31, 2024 | 541,000.00 |
| Sep 30, 2024 | 686,000.00 |
| Jun 30, 2024 | 686,000.00 |
| Mar 31, 2024 | 948,000.00 |
| Dec 31, 2023 | 657,000.00 |
| Sep 30, 2023 | 708,000.00 |
| Jun 30, 2023 | 692,000.00 |
| Mar 31, 2023 | 797,000.00 |
| Dec 31, 2022 | 693,000.00 |
| Sep 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 1.18 Mn |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 1.44 Mn |